Overall, the apparent dual function of TLR9 to act in immune cells (to promote antitumor immunity) or in cancer cells (to promote tumor growth and progression) will likely govern the outcomes of therapeutic TLR9 stimulation in various cancer models, including prostate cancer. The gene discussed is TLR9; the disease is prostate cancer.